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A B S T R A C T
Ischemic retinopathy is a vision-threatening disease associated with chronic retinal inﬂammation and hypoxia
leading to abnormal angiogenesis. Furin, a member of the proprotein convertase family of proteins, has been
implicated in the regulation of angiogenesis due to its essential role in the activation of several angiogenic
growth factors, including vascular endothelial growth factor-C (VEGF-C), VEGF-D and transforming growth
factor - β (TGF- β). In the present study, we evaluated expression of furin in the retina and its role in retinal
angiogenesis. As both inﬂammation and hypoxia contribute to angiogenesis, the role of furin was evaluated
using myeloid-cell speciﬁc furin knockout (KO) mice (designated LysMCre-fur(ﬂ/ﬂ)) both in developmental ret-
inal angiogenesis as well as in hypoxia-driven angiogenesis using the oxygen-induced retinopathy (OIR) model.
In the retina, furin expression was detected in endothelial cells, macrophages and, to some extent, in neurons.
The rate of angiogenesis was not diﬀerent in LysMCre-fur(ﬂ/ﬂ) mice when compared to their wild-type littermates
during development. In the OIR model, the revascularization of retina was signiﬁcantly delayed in LysMCre-
fur(ﬂ/ﬂ) mice compared to their wild-type littermates, while there was no compensatory increase in the preretinal
neovascularization in LysMCre-fur(ﬂ/ﬂ) mice. These results demonstrate that furin expression in myeloid cells
plays a signiﬁcant role in hypoxia-induced angiogenesis in retina.
1. Introduction
Ischemic retinopathies, such as retinopathy of prematurity (ROP),
proliferative diabetic retinopathy (PDR), and retinal vein occlusion
(RVO) are major causes of visual impairment and blindness in in-
dustrialized countries (Fong et al., 2004; Jonas et al., 2017; Reynolds,
2014). Retinal ischemia induces the stabilization of a transcription
factor hypoxia inducible factor-1α (HIF-1α), which turns on the ex-
pression of a large number of angiogenic genes such as vascular en-
dothelial growth factor (VEGF) (Campochiaro, 2015). This leads to
retinal neovascularization associated with vitreous hemorrhages and
ﬁbrosis of neovascular membranes causing tractional retinal detach-
ment and, ultimately, blindness (Campochiaro, 2015).
Retinal ischemia is also associated with inﬂammatory manifesta-
tions. Hypoxia attracts macrophages into hypoxic areas (Mitamura
et al., 2005; Tsutsumi et al., 2003) where the hypoxia-activated mac-
rophages and microglia, the immune cells of the retina, release not only
proinﬂammatory but also angiogenic cytokines. In diabetic retinopathy
(DR), both invading macrophages and resident microglia have been
implicated in the pathogenesis of the retinopathy retinopathy
(Abcouwer, 2012). Of note, macrophages have been shown to be the
main source of VEGF-C in the retina. In the retina, VEGF-C signaling
pathway regulates the branching of blood vessels (Tammela et al.,
2011). VEGF-C is initially synthesized as an inactive precursor and re-
quires activation by a proprotein convertase subtilisin/kexin (PCSK)
family member furin to become biologically active (Siegfried et al.,
2003b).
Proprotein convertase subtilisin/kexin (PCSK) family enzymes are a
family of nine proteases (PCSK1-2, furin, PCSK4-7, MBTPS1, PCSK9)
that cleave and convert their immature target proteins into biologically
active forms by catalyzing endoproteolytic cleavage at a target site
typically made up of the basic amino acids arginine and lysine
(Turpeinen et al., 2013). Accordingly, PCSK enzymes play a key reg-
ulatory role in a multitude of biological events governed by the growth
https://doi.org/10.1016/j.exer.2017.10.013
Received 4 January 2017; Received in revised form 1 September 2017; Accepted 11 October 2017
∗ Corresponding authorFaculty of Medicine & Life Sciences, 33014, University of Tampere, Finland.
E-mail address: llhauus@uta.ﬁ (H. Uusitalo).
Experimental Eye Research 166 (2018) 160–167
Available online 13 October 2017
0014-4835/ © 2017 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
T
factors (Turpeinen et al., 2013). Among the PCSK family members,
furin is a ubiquitously expressed prototypical serine endoprotease re-
cently implicated to play a key role in various biological processes such
autoimmunity and inﬂammation, and various human diseases (Oksanen
et al., 2014; Pesu et al., 2008; Turpeinen et al., 2013; Vähätupa et al.,
2016a). In ﬁbrovascular tissue from PDR patients, furin expression was
shown to co-localize with one of its cleavage targets, a (pro)-renin re-
ceptor protein, whose expression level is elevated in PDR and asso-
ciated with angiogenic activity, suggesting that furin cleavage has a role
in DR (Kanda et al., 2012).
In addition to VEGF-C (Khatib et al., 2010; Siegfried et al., 2003a),
furin is also required for the activation of a large number of other
proangiogenic growth factors, such as VEGF-D (McColl et al., 2007),
platelet derived growth factors A and B (PDGF-A and –B) (Siegfried
et al., 2003b, 2005), bone morphogenetic protein-4 (BMP-4) (Cui et al.,
1998) and transforming growth factor-β (TGF-β) (Dubois et al., 2001).
On the other hand, the expression of furin itself can be induced by
hypoxia, as it is one of the target genes of HIF-1α (Ma et al., 2017;
McMahon et al., 2005; Silvestri et al., 2008). Despite being linked to
angiogenesis, the functions of furin in these processes are still poorly
known, but the phenotype of the total furin knockout (KO) mice,
lethality during embryonal development due to cardiovascular defects,
suggested blood vessel speciﬁc functions (Roebroek et al., 1998;
Scamuﬀa et al., 2006). This notion was conﬁrmed by endothelial spe-
ciﬁc furin KO that also led to embryonal death due to vascular defects,
and by the endothelial cells lacking furin that were unable to grow
ex vivo (Kim et al., 2012).
As endothelial cells lacking furin cannot grow at all (Kim et al.,
2012), we decided to elucidate the role of furin on retinal angiogenesis
by addressing the expression of furin in the retina and by assessing the
eﬀect of myeloid cell-derived furin on retinal angiogenesis using furin
conditional KO mice (myeloid cell-speciﬁc furin KO; LysMCre-fur(ﬂ/ﬂ)).
The eﬀect of myeloid cells-derived furin on angiogenesis was studied in
developmental retinal angiogenesis, as well as in hypoxia-induced an-
giogenesis in a mouse-model for oxygen-induced retinopathy (OIR),
which is the most widely used model for ischemic retinopathies
(Connor et al., 2009; Smith et al., 1994). In the OIR model, both re-
cruited, blood-derived macrophages as well as the resident macro-
phages of the retina, microglia, have been shown to participate in the
regulation of angiogenesis (Checchin et al., 2006; Gao et al., 2016;
Kataoka et al., 2011; Zhou et al., 2015).
2. Results
2.1. Furin is expressed in macrophages and retinal microglia
Using data from published genome-wide expression studies, the
retinal-cell speciﬁc E-GEOD-33089 experiment and the much wider
searching FANTOM project, we extracted expression data for furin in
cells related to retina. In the larger, but far less speciﬁc, FANTOM
project cDNA analysis of furin expression showed the highest values in
monocyte derived macrophages (Fig. 1A). In the retinal cell-speciﬁc
experiment, based on 155 samples analyzed by microarray, the highest
furin expression was found in microglia (Fig. 1B).
2.2. Furin is expressed in the retina during development and in the OIR
model
To further study the role of furin on retinal angiogenesis in vivo, we
ﬁrst determined a temporal and spatial expression proﬁle of furin in WT
mice during development and in the OIR model. Immunohistochemistry
showed a few cells with weak expression of furin in retina at P4
(postnatal day 4), and thereafter the expression of furin was sub-
stantially stronger from P7 onwards at all studied time points during
development (Fig. 1C). In the OIR model, strong expression of furin was
detected in the vascular layers of the retina at P14 and P17 (Fig. 1D).
Using double-immunohistochemistry for furin and for endothelial cells
marker CD31 as well as for furin and macrophage marker F4/80, furin
expression was localized to endothelial cells (Fig. 1E–F) in the retina
and in the preretinal vascular tufts as well as to macrophages sur-
rounding blood vessels (Fig. 1G–H) in OIR retinas. In addition to these
cells, furin immunoreactivity was also detected in neurons in the retina
(Fig. 1).
2.3. Lack of furin in myeloid cells does not inﬂuence the rate of
developmental angiogenesis
To investigate the role of furin in angiogenesis, we studied mice
deﬁcient for furin gene expression in myeloid cells (LysMCre-fur(ﬂ/ﬂ))
and their respective wild-type littermates (LysM WT) during develop-
mental retinal angiogenesis and during ischemia induced retinal an-
giogenesis using oxygen-induced retinopathy model (OIR). LysMCre-
fur(ﬂ/ﬂ) mice are fertile without no obvious morphological abnormal-
ities (Cordova et al., 2016), and their eyes appear normal upon histo-
logical examination. As total depletion of resident retinal macrophages
has been shown to slow down the rate of developmental retinal an-
giogenesis (Checchin et al., 2006), we ﬁrst explored whether myeloid
cell derived furin inﬂuences the rate of superﬁcial vascular plexus
formation (developmental angiogenesis) in retinas from P6 LysM WT
and LysMCre-fur(ﬂ/ﬂ). In P6 neonatal mice, the diameters of retinal
superﬁcial vascular plexuses were similar and no diﬀerences in either
the number of branching points or ﬁlopodia count were detected be-
tween LysMCre-fur(ﬂ/ﬂ) and LysM WT mice, indicating that furin ex-
pression by myeloid cells does not have a major inﬂuence on in vivo
angiogenesis during neonatal development (Fig. 2A–E). This ﬁnding is
in line with the above reported appearance of furin at the late stages of
retinal vascular development (Fig. 1C).
2.4. Mice deﬁcient for furin expression in myeloid cells show reduced
hypoxic revascularization rate of the retina
The role of myeloid cell derived furin in hypoxia-driven neovascu-
larization in the retina was explored next. First, we determined whether
regression of vessels under hyperoxic conditions in the OIR model is
comparable between LysMCre-fur(ﬂ/ﬂ) and LysM WT mice. After ex-
posure to 75% oxygen between P7 and P12, retinas were evaluated at
P12. Typical for this model (Smith et al., 1994; Uusitalo-Järvinen et al.,
2007; Vähätupa et al., 2016b), large areas of the central vascular net-
work were regressed with only a few major vessels remaining centrally
in both LysM WT and LysMCre-fur(ﬂ/ﬂ) mice (Fig. 2F). Quantitative
analysis of vaso-obliterated areas in retina conﬁrmed that the retinal
vasculature in LysMCre-fur(ﬂ/ﬂ) and LysM WT mice was similarly af-
fected by hyperoxic exposure (Fig. 2G). Taken together, these data
suggest that deletion of furin from myeloid cells has not a signiﬁcant
eﬀect on vascular regression in OIR model.
On return to normoxia, the avascular central retina becomes hy-
poxic and stimulates rapid regrowth of vessels (Smith et al., 1994;
Uusitalo-Järvinen et al., 2007). The rate of retinal revascularization in
LysM WT and LysMCre-fur(ﬂ/ﬂ) retinas was determined by quantifying
the avascular retinal area 5 days after the mice were returned to nor-
moxia. There was a statistically signiﬁcant diﬀerence in the avascular
retinal area between the LysM WT and LysMCre-fur(ﬂ/ﬂ) mice at P17
showing that the rate of retinal revascularization is substantially (30%)
reduced in mice where furin is depleted from myeloid cells (Fig. 2J). In
addition to revascularization of the retina, the strong hypoxic stimulus
from the center of the retina also drives abnormal misdirected sprouting
of blood vessels towards the vitreous at the interface between the
centrally obliterated and peripherally perfused retina (Smith et al.,
1994; Uusitalo-Järvinen et al., 2007). This pathological, preretinal
neovascularization reaches its maximum 5 days after return to nor-
moxia (at P17). There was no statistically signiﬁcant diﬀerence in the
amount of preretinal neovascularization between LysM WT and
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LysMCre-fur(ﬂ/ﬂ) retinas (Fig. 2K). The results indicate that myeloid cell
expressed furin has a role in hypoxia-induced revascularization in re-
tina, but does not inﬂuence the pathological preretinal neovascular-
ization.
3. Discussion
The present study demonstrates that macrophages associated with
retinal blood vessels express furin and the lack of furin in myeloid cells
delays hypoxia-driven angiogenesis in retina. It has previously been
shown that the endothelial speciﬁc deﬁciency of furin leads to embry-
onal death due to vascular defects (Roebroek et al., 1998), and the
cultured endothelial cells lacking furin cannot grow (Kim et al., 2012).
Our results conﬁrm an important role for furin in angiogenesis as we
show for the ﬁrst time that furin deﬁciency in myeloid cells leads to
impaired angiogenesis in hypoxia-induced retinal angiogenesis.
Previous studies have shown that resident macrophages, microglia,
are needed for proper angiogenesis in retina during both developmental
and hypoxia-induced angiogenesis (Checchin et al., 2006). In this study,
we demonstrate that myeloid-cell speciﬁc deletion of proprotein con-
vertase furin leads to the attenuation of angiogenesis and reduced
vascularization rate in OIR model. Among furin's target proteins are
several proangiogenic growth factors, including VEGF-C which is ex-
pressed in macrophages and has a role in controlling the branching of
blood vessels in the retina (Siegfried et al., 2003a; Tammela et al.,
2011). VEGF-A, in turn, does not require activating cleavage by furin.
Interestingly, a myeloid-cell speciﬁc ablation of VEGF-A expression
does not change the VEGF levels in the OIR and does not have any
inﬂuence on angiogenesis in the OIR model (Liyanage et al., 2016).
Although further studies concerning the role of furin in retinal angio-
genesis are required, our results suggest that the expression of furin in
macrophages may be related to activation of proangiogenic growth
factors by furin in the retina. This is in line with previous studies
showing simultaneous induction of VEGF-C and furin expression in
diﬀerent disease models (Khatib et al., 2010; Lopez de Cicco et al.,
2004; Siegfried et al., 2003a).
A major function of furin is to control the bioavailability of anti-
inﬂammatory TGF-β1 (Pesu et al., 2008). As a matter of fact, both furin
and TGF-β are involved in the regulation of each other's activity; furin is
needed for the activation of diﬀerent TGF-β isoforms from inactive
precursor molecules to active, mature forms (Pesu et al., 2008; Ventura
et al., 2017). The active TGF-β2, in turn, induces furin expression
(Ventura et al., 2017). Thus, together they generate a self-sustaining
loop for high TGF-β activity (Ventura et al., 2017). TGF-β signaling is
associated with neovascularization in many diseases, including neo-
vascular ocular diseases (Amin et al., 1994; Bai et al., 2014; Wang et al.,
2017). The expression of TGF-β is elevated in the OIR model, suggesting
that TGF-β signaling contributes to retinal revascularization
(Yingchuan et al., 2010). A previous study has shown that the TGF-β1
bioactivity is reduced in mice deﬁcient in furin expression in myeloid
cells (Cordova et al., 2016). Thus, another plausible explanation for the
reduction of revascularization in the retina of LysMCre-fur(ﬂ/ﬂ) mice
could be the reduced bioavailability of TGF-β due to lack of activating
furin.
Although retinal revascularization rate and the formation of pa-
thological preretinal tufts are inter-related in the OIR model, we
identiﬁed a delayed revascularization rate in retina without a sub-
sequent increase of pathological preretinal tuft formation in LysMCre-
fur(ﬂ/ﬂ) mice in the OIR model. One explanation is that resident mac-
rophages, microglia, persist in the retina in response to ﬁve-day long
hyperoxia despite blood vessels disappearing completely from retina
(Davies et al., 2006). Once the revascularization is initiated upon return
to normoxia, i.e. induction of hypoxia in retina, resident microglial cells
respond to hypoxia by secreting proangiogenic growth factors and di-
rect the revascularization, but selectively only in retina, where they are
located. This notion is supported by the facts that the microglia are
mainly located in the avascular areas after the hyperoxia-period and the
function of macrophage-derived VEGF-C is to convert the tip cells to
stalk cells during retinal angiogenesis (Tammela et al., 2011). The lack
of inﬂuence on preretinal pathological revascularization in the
LysMCre-fur(ﬂ/ﬂ) mice is rather striking because we observed sig-
niﬁcantly larger avascular areas in LysMCre-fur(ﬂ/ﬂ) mice than in WT
mice. This, in turn, should theoretically induce more pronounced
compensatory preretinal pathological tuft formation, but we could not
demonstrate that. An explanation why larger avascular retinal area
does not translate into enhanced preretinal neovascularization, may be
impaired proangiogenic growth factor activation in LysMCre-fur(ﬂ/ﬂ)
mice.
Taken together our study demonstrates that the lack of furin in
myeloid cells delays hypoxia-driven angiogenesis in retina and im-
plicates furin expressed outside of the endothelial cells to the regulation
of hypoxia-induced angiogenesis.
4. Methods
4.1. Mice
Monocyte/Macrophage-speciﬁc furin conditional knockout
LysMCre-fur(ﬂ/ﬂ) was generated as described previously (Cordova et al.,
2016). Brieﬂy, mice bearing ﬂoxed fur alleles were backcrossed six
times with C57BL/6 mice. LysMCre mice on C57BL/6 background were
purchased from Taconic. LysMCre mice were bred with fur(ﬂ/ﬂ) animals
to generate myeloid-speciﬁc furin knockout mice LysMCre-fur(ﬂ/ﬂ).
Mice were housed under pathogen-free standard conditions, bred and
the genotype was determined by PCR. Mice were fed with standard
laboratory pellets and water ad libitum. All animal experiments were
performed according to the ARVO statement for the use of animals in
ophthalmic and vision research in accordance with protocols approved
by the National Animal Ethics Committee of Finland.
4.2. Oxygen-induced retinopathy (OIR) model
The experiments on OIR model were carried out as described in
detail previously (Smith et al., 1994; Stahl et al., 2010b; Uusitalo-
Järvinen et al., 2007; Vähätupa et al., 2016b). Brieﬂy, neonatal mice at
P7 and their nursing mother were exposed to 75% oxygen for 5 days. At
P12, the mice were returned to normal room air. Animals were eu-
thanized at P12 to assess the degree of vascular regression and at P17 to
determine the rate of retinal revascularization and preretinal neo-
vascularization. As postnatal weight gain has been shown to aﬀect
outcome in the OIR model, the pups included in the study were weight-
matched (Stahl et al., 2010a).
Fig. 1. Furin is expressed by the endothelial cells and macrophages in retina. Using expression data from the FANTOM 5 project, cDNA expression data was extracted for the primary
furin CAGE for relevant cell types (A). Expression data for furin in diﬀerent retinal cell types was extracted from previously performed microarray expression analysis (B). In panels A–B
the cell types are sorted by increasing average expression from left to right. Furin expression from retina was determined during developmental angiogenesis at P4, P7 and P14 and in OIR
model at P14 and P17 from the revascularized retinas by IHC and IF using furin speciﬁc antibody. Representative images of furin expression during development (C) and in the OIR model
(D). Arrows are pointing furin speciﬁc staining at P17 OIR. Scale bars represents 100 μm. Representative confocal images showing CD31 positive endothelial cells (red) and furin (green)
(E–F) and F4/80 positive macrophages (red) and furin (green) (G–H) in the retina of frozen sections after immunoﬂuorescence staining. Panels E and G are showing stainings at 20×
magniﬁcation and panels F and H at 63× magniﬁcation. Arrows are pointing the endothelial cells or macrophages that are expressing furin. Arrowheads are pointing neovascular tufts.
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, outer plexiform layer; ONL, outer nuclear layer; IS/OS, photoreceptor inner/outer segments; RPE,
retinal pigment epithelium. Scale bars represents 100 μm in E and G and 20 μm in F and H.
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4.3. FANTOM analysis of retinal cell types
The FANTOM project has performed expression analysis on 1839
samples from 573 primary cells, 152 tissues, and 250 cell lines in
human. Speciﬁcally, the data comes from cap analysis gene expression
(CAGE) sequencing of cDNA (FANTOM Consortium et al., 2014). Ex-
pression data was extracted for the primary furin CAGE for relevant cell
types: endothelial cells, pericytes, astrocytes, retinal pigment epithe-
lium cells, neurons, neutrophils, endothelial progenitor cells, corneal
epithelial cells and monocyte derived macrophages.
4.4. Microarray analysis of retinal cell types
A microarray expression analysis of mouse genes in various retinal
cell type groups was performed previously and is stored as accession E-
GEOD-33089 on the ArrayExpress database (https://www.ebi.ac.uk/
arrayexpress/experiments/E-GEOD-33089). From the data we ex-
tracted furin gene expression values for 155 samples across 7 cell type
groups: amacrine, cone, rod, bipolar, horizontal, ganglion, and micro-
glia (Siegert et al., 2012). Both FANTOM and microarray analyses were
performed utilizing supercomputer resources provided by CSC–IT
Center for Science of the Finnish Ministry of Education and Culture and
the raw data was processed as previously described in detail elsewhere
(Barker et al., 2017).
4.5. Immunohistochemistry (IHC) and isolectin GS-IB4 staining
For immunohistochemistry, the eyes were ﬁxed with 4% PFA and
embedded in paraﬃn (for IHC), or freshly frozen in OCT embedding
compound in liquid nitrogen cooled isopentane and later ﬁxed with
methanol (for immunoﬂuorescence). The IHC stainings were carried
out on 4–6 μm thick tissue sections using the following primary anti-
bodies: rabbit anti-furin, (H-220), (Santa Cruz Biotechnology, Dallas,
TX), rat anti-CD31 (BD Pharmingen, San Diego, CA) and rat anti-F4/80
(Life Technologies, Paisley, UK) followed by horseradish peroxidase
(HRP) or ﬂuorescein-conjugated secondary antibodies. Hematoxylin
staining was used as a counterstain. IF samples were mounted with
Vectashield mounting medium with DAPI (Vector Laboratories,
Burlingame, CA) and images were taken with confocal microscope (Carl
Zeiss LSM 700). As a negative control, each staining included sections
stained without primary antibody.
4.6. Quantitative analysis of angiogenesis
For the analysis of retinal vasculature, eyes were enucleated, ﬁxed
with 4% PFA and retinas dissected. Flat mount retinas were blocked in
10% normal goat serum for 2 h, incubated overnight with Isolectin GS-
IB4 (1:200, Invitrogen, Carlsbad, CA) Retinas were imaged via confocal
microscope (Carl Zeiss LSM 700) and the rate of angiogenesis was de-
termined during development (P6) and in the OIR model as previously
described (Connor et al., 2009; Stahl et al., 2010b). Brieﬂy, retinas were
imaged using confocal microscopy (Carl Zeiss LSM 700) with 10 × ob-
jective by focusing on the preretinal neovascular tufts and the under-
lying superﬁcial vascular plexus. Areas of vascular obliteration and
pathological neovascularization (neovascular tufts) were computed, in
pixels, and divided by the total retinal area using Adobe Photoshop
CS3. The rate of developmental angiogenesis at P6 was determined by
measuring the diameter of vasculature via the optic nerve to the tips of
the blood vessels. Analysis of vessel branching and number of ﬁlopodia
sprouts were quantiﬁed as previously described (Lobov et al., 2007).
Each point where three capillary segments met was counted as one
junction. Branch points from the capillary plexus from two areas
(370 μm × 550 μm) per retina were counted and results are shown by
the average count per unit area. The number of ﬁlopodia protrusions
from the tip cells were counted from the length of 500 μm of the
sprouting vascular front (two measures per retina).
4.7. Statistical analysis
Student's t-test was conducted for normally distributed data and
nonparametric Mann-Whitney U test (GraphPad Prism 6.01 and IBM
SPSS statistics) for non-normally distributed data to test the statistical
signiﬁcance of the results. P-values less than 0.05 were considered
statistically signiﬁcant.
5. Statement of author contributions
M.V, T.J and H. U-J designed the research. M.V and H.B. performed
the research. M.V, H.B, T.J and H. U-J analyzed the data. M.P, S.A and
Z.M.C provided LysMCre-fur(ﬂ/ﬂ) mice for the study. M.V contributed
the genotyped mice littermates. M.V, Z.M.C, H.B, T.J and H. U-J wrote
the manuscript. M.V made the ﬁgures. All authors reviewed the paper.
Conﬂict of interest statement
The authors declare no conﬂict of interest.
Acknowledgements
We thank Marianne Karlsberg for excellent technical assistance. The
work was supported by the Sigrid Juselius Foundation, the Academy of
Finland, Päivikki and Sakari Sohlberg Foundation, Instrumentarium
Research Foundation, Finnish Medical Foundation, Pirkanmaa Hospital
District Research Foundation and the Finnish Cultural Foundation,
Finnish Diabetic Research Foundation, Finnish Eye Foundation.
References
Abcouwer, S.F., 2012. Neural inﬂammation and the microglial response in diabetic re-
tinopathy. J. Ocul. Biol. Dis. Infor 4, 25–33.
Amin, R., Puklin, J.E., Frank, R.N., 1994. Growth factor localization in choroidal neo-
vascular membranes of age-related macular degeneration. Invest. Ophthalmol. Vis.
Sci. 35, 3178–3188.
Bai, Y., Liang, S., Yu, W., Zhao, M., Huang, L., Zhao, M., Li, X., 2014. Semaphorin 3A
blocks the formation of pathologic choroidal neovascularization induced by trans-
forming growth factor β. Mol. Vis. 20, 1258–1270.
Barker, H., Aaltonen, M., Pan, P., Vähätupa, M., Kaipiainen, P., May, U., Prince, S.,
Uusitalo-Järvinen, H., Waheed, A., Pastorekova, S., Sly, W.S., Parkkila, S., Järvinen,
T.A., 2017. Role of carbonic anhydrases in skin wound healing. Exp. Mol. Med. 49,
e334.
Campochiaro, P.A., 2015. Molecular pathogenesis of retinal and choroidal vascular dis-
eases. Prog. Retin. Eye Res. 49, 67–81.
Checchin, D., Sennlaub, F., Levavasseur, E., Leduc, M., Chemtob, S., 2006. Potential role
of microglia in retinal blood vessel formation. Invest. Ophthalmol. Vis. Sci. 47,
Fig. 2. Furin deﬁciency in myeloid cells inhibits revascularization rate in the retina during the OIR model. Eyes were harvested from healthy and LysMCre-fur(ﬂ/ﬂ) mice at P6
when the development of the superﬁcial vascular plexus has occurred and in the OIR model at P12 and P17. Retinas were ﬁxed with 4% PFA, ﬂat mounted and stained with Alexa Fluor
conjugated Isolectin IB4. (A) The rate of early angiogenesis was quantiﬁed in retinal ﬂat mounts by measuring the length of vasculature via the optic nerve. (B) There was no diﬀerence in
the length of angiogenic vasculature of superﬁcial vascular plexus between WT and LysMCre-fur(ﬂ/ﬂ) retinas at P6. (C) The number of branch points (white dots) in retinal vascular plexus
and ﬁlopodia protrusions (yellow dots) from tip cells were counted from P6 retinas. The results are expressed as the number of branch points per unit area (D) and ﬁlopodia per 500 μm of
vascular front (E). Both outcomes were similar between genotypes. WT n = 7 and KO n = 6. (F) Representative images of retinas right after the hyperoxic phase of OIR at P12. (G)
Quantitative analysis of the avascular areas (inside the white line) shows that the vascular regression is similar in WT and LysMCre-fur(ﬂ/ﬂ) animals. (WT n = 4, KO n = 7 retinas.) (H)
Representative OIR model retinas of WT and LysMCre-fur(ﬂ/ﬂ) mice at P17. (I) The avascular areas (yellow) and preretinal pathological neovascularization (tufts, white) were quantiﬁed.
(J) Revascularization rate of retina is reduced by 30% (p = 0.012) in the LysMCre-fur(ﬂ/ﬂ) mice, while no diﬀerences were detected in the pathological revascularization, i.e. in the
preretinal tufts (K). (WT n = 26 and KO n = 19 retinas.) Scale bar represents 1 mm in A, F, H and I and 200 μm in C. Error bars represent SDs.
M. Vähätupa et al. Experimental Eye Research 166 (2018) 160–167
165
3595–3602.
Connor, K.M., Krah, N.M., Dennison, R.J., Aderman, C.M., Chen, J., Guerin, K.I., Sapieha,
P., Stahl, A., Willett, K.L., Smith, L.E., 2009. Quantiﬁcation of oxygen-induced re-
tinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological
angiogenesis. Nat. Protoc. 4, 1565–1573.
Cordova, Z.M., Gronholm, A., Kytola, V., Taverniti, V., Hamalainen, S., Aittomäki, S.,
Niininen, W., Junttila, I., Ylipaa, A., Nykter, M., Pesu, M., 2016. Myeloid cell ex-
pressed proprotein convertase FURIN attenuates inﬂammation. Oncotarget 23
7(34):54392–54404.
Cui, Y., Jean, F., Thomas, G., Christian, J.L., 1998. BMP-4 is proteolytically activated by
furin and/or PC6 during vertebrate embryonic development. EMBO J. 17,
4735–4743.
Davies, M.H., Eubanks, J.P., Powers, M.R., 2006. Microglia and macrophages are in-
creased in response to ischemia-induced retinopathy in the mouse retina. Mol. Vis.
12, 467–477.
Dubois, C.M., Blanchette, F., Laprise, M.H., Leduc, R., Grondin, F., Seidah, N.G., 2001.
Evidence that furin is an authentic transforming growth factor-β1-converting en-
zyme. Am. J. Pathol. 158, 305–316.
FANTOM Consortium, the RIKEN PMI, CLST (DGT),Forrest, A.R., Kawaji, H., Rehli, M.,
Baillie, J.K., de Hoon, M.J., Haberle, V., Lassmann, T., Kulakovskiy, I.V., Lizio, M.,
Itoh, M., Andersson, R., Mungall, C.J., Meehan, T.F., Schmeier, S., Bertin, N.,
Jorgensen, M., Dimont, E., Arner, E., Schmidl, C., Schaefer, U., Medvedeva, Y.A.,
Plessy, C., Vitezic, M., Severin, J., Semple, C., Ishizu, Y., Young, R.S., Francescatto,
M., Alam, I., Albanese, D., Altschuler, G.M., Arakawa, T., Archer, J.A., Arner, P.,
Babina, M., Rennie, S., Balwierz, P.J., Beckhouse, A.G., Pradhan-Bhatt, S., Blake, J.A.,
Blumenthal, A., Bodega, B., Bonetti, A., Briggs, J., Brombacher, F., Burroughs, A.M.,
Califano, A., Cannistraci, C.V., Carbajo, D., Chen, Y., Chierici, M., Ciani, Y., Clevers,
H.C., Dalla, E., Davis, C.A., Detmar, M., Diehl, A.D., Dohi, T., Drablos, F., Edge, A.S.,
Edinger, M., Ekwall, K., Endoh, M., Enomoto, H., Fagiolini, M., Fairbairn, L., Fang,
H., Farach-Carson, M.C., Faulkner, G.J., Favorov, A.V., Fisher, M.E., Frith, M.C.,
Fujita, R., Fukuda, S., Furlanello, C., Furino, M., Furusawa, J., Geijtenbeek, T.B.,
Gibson, A.P., Gingeras, T., Goldowitz, D., Gough, J., Guhl, S., Guler, R., Gustincich,
S., Ha, T.J., Hamaguchi, M., Hara, M., Harbers, M., Harshbarger, J., Hasegawa, A.,
Hasegawa, Y., Hashimoto, T., Herlyn, M., Hitchens, K.J., Ho Sui, S.J., Hofmann, O.M.,
Hoof, I., Hori, F., Huminiecki, L., Iida, K., Ikawa, T., Jankovic, B.R., Jia, H., Joshi, A.,
Jurman, G., Kaczkowski, B., Kai, C., Kaida, K., Kaiho, A., Kajiyama, K., Kanamori-
Katayama, M., Kasianov, A.S., Kasukawa, T., Katayama, S., Kato, S., Kawaguchi, S.,
Kawamoto, H., Kawamura, Y.I., Kawashima, T., Kempﬂe, J.S., Kenna, T.J., Kere, J.,
Khachigian, L.M., Kitamura, T., Klinken, S.P., Knox, A.J., Kojima, M., Kojima, S.,
Kondo, N., Koseki, H., Koyasu, S., Krampitz, S., Kubosaki, A., Kwon, A.T., Laros, J.F.,
Lee, W., Lennartsson, A., Li, K., Lilje, B., Lipovich, L., Mackay-Sim, A., Manabe, R.,
Mar, J.C., Marchand, B., Mathelier, A., Mejhert, N., Meynert, A., Mizuno, Y., de Lima
Morais, D.A., Morikawa, H., Morimoto, M., Moro, K., Motakis, E., Motohashi, H.,
Mummery, C.L., Murata, M., Nagao-Sato, S., Nakachi, Y., Nakahara, F., Nakamura, T.,
Nakamura, Y., Nakazato, K., van Nimwegen, E., Ninomiya, N., Nishiyori, H., Noma,
S., Noma, S., Noazaki, T., Ogishima, S., Ohkura, N., Ohimiya, H., Ohno, H., Ohshima,
M., Okada-Hatakeyama, M., Okazaki, Y., Orlando, V., Ovchinnikov, D.A., Pain, A.,
Passier, R., Patrikakis, M., Persson, H., Piazza, S., Prendergast, J.G., Rackham, O.J.,
Ramilowski, J.A., Rashid, M., Ravasi, T., Rizzu, P., Roncador, M., Roy, S., Rye, M.B.,
Saijyo, E., Sajantila, A., Saka, A., Sakaguchi, S., Sakai, M., Sato, H., Savvi, S., Saxena,
A., Schneider, C., Schultes, E.A., Schulze-Tanzil, G.G., Schwegmann, A., Sengstag, T.,
Sheng, G., Shimoji, H., Shimoni, Y., Shin, J.W., Simon, C., Sugiyama, D., Sugiyama,
T., Suzuki, M., Suzuki, N., Swoboda, R.K., t Hoen, P.A., Tagami, M., Takahashi, N.,
Takai, J., Tanaka, H., Tatsukawa, H., Tatum, Z., Thompson, M., Toyodo, H., Toyoda,
T., Valen, E., van de Wetering, M., van den Berg, L.M., Verado, R., Vijayan, D.,
Vorontsov, I.E., Wasserman, W.W., Watanabe, S., Wells, C.A., Winteringham, L.N.,
Wolvetang, E., Wood, E.J., Yamaguchi, Y., Yamamoto, M., Yoneda, M., Yonekura, Y.,
Yoshida, S., Zabierowski, S.E., Zhang, P.G., Zhao, X., Zucchelli, S., Summers, K.M.,
Suzuki, H., Daub, C.O., Kawai, J., Heutink, P., Hide, W., Freeman, T.C., Lenhard, B.,
Bajic, V.B., Taylor, M.S., Makeev, V.J., Sandelin, A., Hume, D.A., Carninci, P.,
Hayashizaki, Y., 2014. A promoter-level mammalian expression atlas. Nature 507,
462–470.
Fong, D.S., Aiello, L., Gardner, T.W., King, G.L., Blankenship, G., Cavallerano, J.D., Ferris
3rd, F.L., Klein, R., American Diabetes Association, 2004. Retinopathy in diabetes.
Diabetes Care 27 (Suppl. 1), S84–S87.
Gao, X., Wang, Y.S., Li, X.Q., Hou, H.Y., Su, J.B., Yao, L.B., Zhang, J., 2016. Macrophages
promote vasculogenesis of retinal neovascularization in an oxygen-induced retino-
pathy model in mice. Cell Tissue Res. 364, 599–610.
Jonas, J.B., Mones, J., Glacet-Bernard, A., Coscas, G., 2017. Retinal vein occlusions. Dev.
Ophthalmol. 58, 139–167.
Kanda, A., Noda, K., Saito, W., Ishida, S., 2012. (Pro)renin receptor is associated with
angiogenic activity in proliferative diabetic retinopathy. Diabetologia 55,
3104–3113.
Kataoka, K., Nishiguchi, K.M., Kaneko, H., van Rooijen, N., Kachi, S., Terasaki, H., 2011.
The roles of vitreal macrophages and circulating leukocytes in retinal neovascular-
ization. Invest. Ophthalmol. Vis. Sci. 52, 1431–1438.
Khatib, A.M., Lahlil, R., Scamuﬀa, N., Akimenko, M.A., Ernest, S., Lomri, A., Lalou, C.,
Seidah, N.G., Villoutreix, B.O., Calvo, F., Siegfried, G., 2010. Zebraﬁsh ProVEGF-C
expression, proteolytic processing and inhibitory eﬀect of unprocessed ProVEGF-C
during ﬁn regeneration. PLoS One 5, e11438.
Kim, W., Essalmani, R., Szumska, D., Creemers, J.W., Roebroek, A.J., D'Orleans-Juste, P.,
Bhattacharya, S., Seidah, N.G., Prat, A., 2012. Loss of endothelial furin leads to
cardiac malformation and early postnatal death. Mol. Cell. Biol. 32, 3382–3391.
Liyanage, S.E., Fantin, A., Villacampa, P., Lange, C.A., Denti, L., Cristante, E., Smith, A.J.,
Ali, R.R., Luhmann, U.F., Bainbridge, J.W., Ruhrberg, C., 2016. Myeloid-derived
vascular endothelial growth factor and hypoxia-inducible factor are dispensable for
ocular neovascularization–brief report. Arterioscler. Thromb. Vasc. Biol. 36, 19–24.
Lobov, I.B., Renard, R.A., Papadopoulos, N., Gale, N.W., Thurston, G., Yancopoulos, G.D.,
Wiegand, S.J., 2007. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative
regulator of angiogenic sprouting. Proc. Natl. Acad. Sci. U. S. A. 104, 3219–3224.
Lopez de Cicco, R., Watson, J.C., Bassi, D.E., Litwin, S., Klein-Szanto, A.J., 2004.
Simultaneous expression of furin and vascular endothelial growth factor in human
oral tongue squamous cell carcinoma progression. Clin. Cancer Res. 10, 4480–4488.
Ma, J., Evrard, S., Badiola, I., Siegfried, G., Khatib, A.M., 2017. Regulation of the pro-
protein convertases expression and activity during regenerative angiogenesis: role of
hypoxia-inducible factor (HIF). Eur. J. Cell Biol. 96, 457–468.
McColl, B.K., Paavonen, K., Karnezis, T., Harris, N.C., Davydova, N., Rothacker, J., Nice,
E.C., Harder, K.W., Roufail, S., Hibbs, M.L., Rogers, P.A., Alitalo, K., Stacker, S.A.,
Achen, M.G., 2007. Proprotein convertases promote processing of VEGF-D, a critical
step for binding the angiogenic receptor VEGFR-2. FASEB J. 21, 1088–1098.
McMahon, S., Grondin, F., McDonald, P.P., Richard, D.E., Dubois, C.M., 2005. Hypoxia-
enhanced expression of the proprotein convertase furin is mediated by hypoxia-in-
ducible factor-1: impact on the bioactivation of proproteins. J. Biol. Chem. 280,
6561–6569.
Mitamura, Y., Harada, C., Harada, T., 2005. Role of cytokines and trophic factors in the
pathogenesis of diabetic retinopathy. Curr. Diabetes Rev. 1, 73–81.
Oksanen, A., Aittomäki, S., Jankovic, D., Ortutay, Z., Pulkkinen, K., Hamalainen, S.,
Rokka, A., Corthals, G.L., Watford, W.T., Junttila, I., O'Shea, J.J., Pesu, M., 2014.
Proprotein convertase FURIN constrain Th2 diﬀerentiation and is critical for host
resistance against Toxoplasma gondii. J. Immunol. 193, 5470–5479.
Pesu, M., Watford, W.T., Wei, L., Xu, L., Fuss, I., Strober, W., Andersson, J., Shevach,
E.M., Quezado, M., Bouladoux, N., Roebroek, A., Belkaid, Y., Creemers, J., O'Shea,
J.J., 2008. T-cell-expressed proprotein convertase furin is essential for maintenance
of peripheral immune tolerance. Nature 455, 246–250.
Reynolds, J.D., 2014. Insights in ROP. Am. Orthopt. J. 64, 43–53.
Roebroek, A.J., Umans, L., Pauli, I.G., Robertson, E.J., van Leuven, F., Van de Ven, W.J.,
Constam, D.B., 1998. Failure of ventral closure and axial rotation in embryos lacking
the proprotein convertase Furin. Development 125, 4863–4876.
Scamuﬀa, N., Calvo, F., Chretien, M., Seidah, N.G., Khatib, A.M., 2006. Proprotein con-
vertases: lessons from knockouts. FASEB J. 20, 1954–1963.
Siegert, S., Cabuy, E., Scherf, B.G., Kohler, H., Panda, S., Le, Y.Z., Fehling, H.J., Gaidatzis,
D., Stadler, M.B., Roska, B., 2012. Transcriptional code and disease map for adult
retinal cell types. Nat. Neurosci. 15 487–495, S1-2.
Siegfried, G., Basak, A., Cromlish, J.A., Benjannet, S., Marcinkiewicz, J., Chretien, M.,
Seidah, N.G., Khatib, A.M., 2003a. The secretory proprotein convertases furin, PC5,
and PC7 activate VEGF-C to induce tumorigenesis. J. Clin. Invest. 111, 1723–1732.
Siegfried, G., Khatib, A.M., Benjannet, S., Chretien, M., Seidah, N.G., 2003b. The pro-
teolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members
of the proprotein convertase family is functionally correlated to platelet-derived
growth factor-A-induced functions and tumorigenicity. Cancer Res. 63, 1458–1463.
Siegfried, G., Basak, A., Prichett-Pejic, W., Scamuﬀa, N., Ma, L., Benjannet, S., Veinot,
J.P., Calvo, F., Seidah, N., Khatib, A.M., 2005. Regulation of the stepwise proteolytic
cleavage and secretion of PDGF-B by the proprotein convertases. Oncogene 24,
6925–6935.
Silvestri, L., Pagani, A., Camaschella, C., 2008. Furin-mediated release of soluble hemo-
juvelin: a new link between hypoxia and iron homeostasis. Blood 111, 924–931.
Smith, L.E., Wesolowski, E., McLellan, A., Kostyk, S.K., D'Amato, R., Sullivan, R.,
D'Amore, P.A., 1994. Oxygen-induced retinopathy in the mouse. Invest. Ophthalmol.
Vis. Sci. 35, 101–111.
Stahl, A., Chen, J., Sapieha, P., Seaward, M.R., Krah, N.M., Dennison, R.J., Favazza, T.,
Bucher, F., Lofqvist, C., Ong, H., Hellstrom, A., Chemtob, S., Akula, J.D., Smith, L.E.,
2010a. Postnatal weight gain modiﬁes severity and functional outcome of oxygen-
induced proliferative retinopathy. Am. J. Pathol. 177, 2715–2723.
Stahl, A., Connor, K.M., Sapieha, P., Chen, J., Dennison, R.J., Krah, N.M., Seaward, M.R.,
Willett, K.L., Aderman, C.M., Guerin, K.I., Hua, J., Lofqvist, C., Hellstrom, A., Smith,
L.E., 2010b. The mouse retina as an angiogenesis model. Invest. Ophthalmol. Vis. Sci.
51, 2813–2826.
Tammela, T., Zarkada, G., Nurmi, H., Jakobsson, L., Heinolainen, K., Tvorogov, D.,
Zheng, W., Franco, C.A., Murtomaki, A., Aranda, E., Miura, N., Yla-Herttuala, S.,
Fruttiger, M., Makinen, T., Eichmann, A., Pollard, J.W., Gerhardt, H., Alitalo, K.,
2011. VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing
Notch signalling. Nat. Cell Biol. 13, 1202–1213.
Tsutsumi, C., Sonoda, K.H., Egashira, K., Qiao, H., Hisatomi, T., Nakao, S., Ishibashi, M.,
Charo, I.F., Sakamoto, T., Murata, T., Ishibashi, T., 2003. The critical role of ocular-
inﬁltrating macrophages in the development of choroidal neovascularization.
J. Leukoc. Biol. 74, 25–32.
Turpeinen, H., Ortutay, Z., Pesu, M., 2013. Genetics of the ﬁrst seven proprotein con-
vertase enzymes in health and disease. Curr. Genomics 14, 453–467.
Uusitalo-Järvinen, H., Kurokawa, T., Mueller, B.M., Andrade-Gordon, P., Friedlander, M.,
Ruf, W., 2007. Role of protease activated receptor 1 and 2 signaling in hypoxia-
induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 27, 1456–1462.
Vähätupa, M., Aittomäki, S., Martinez Cordova, Z., May, U., Prince, S., Uusitalo-Järvinen,
H., Järvinen, T.A., Pesu, M., 2016a. T-cell-expressed proprotein convertase FURIN
inhibits DMBA/TPA-induced skin cancer development. Oncoimmunology 5,
e1245266.
Vähätupa, M., Prince, S., Vataja, S., Mertimo, T., Kataja, M., Kinnunen, K., Marjomaki, V.,
Uusitalo, H., Komatsu, M., Järvinen, T.A., Uusitalo-Järvinen, H., 2016b. Lack of r-ras
leads to increased vascular permeability in ischemic retinopathy. Invest. Ophthalmol.
Vis. Sci. 57, 4898–4909.
Ventura, E., Weller, M., Burghardt, I., 2017. Cutting edge: ERK1 mediates the autocrine
positive feedback loop of TGFβ and furin in glioma-initiating cells. J. Immunol. 198,
4569–4574.
M. Vähätupa et al. Experimental Eye Research 166 (2018) 160–167
166
Wang, X., Ma, W., Han, S., Meng, Z., Zhao, L., Yin, Y., Wang, Y., Li, J., 2017. TGFβ
participates choroid neovascularization through Smad2/3-VEGF/TNF-α signaling in
mice with Laser-induced wet age-related macular degeneration. Sci. Rep. 7
9672–017-10124-4.
Yingchuan, F., Chuntao, L., Hui, C., Jianbin, H., 2010. Increased expression of TGF-β1 and
Smad 4 on oxygen-induced retinopathy in neonatal mice. Adv. Exp. Med. Biol. 664,
71–77.
Zhou, Y., Yoshida, S., Nakao, S., Yoshimura, T., Kobayashi, Y., Nakama, T., Kubo, Y.,
Miyawaki, K., Yamaguchi, M., Ishikawa, K., Oshima, Y., Akashi, K., Ishibashi, T.,
2015. M2 macrophages enhance pathological neovascularization in the mouse model
of oxygen-induced retinopathy. Invest. Ophthalmol. Vis. Sci. 56, 4767–4777.
M. Vähätupa et al. Experimental Eye Research 166 (2018) 160–167
167
